← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1988Last known activity
Aug 31, 2026
Timeline
1950s
- Jan 1, 1950
National Institute of Neurological Disorders and Stroke (NINDS)— Founded
Drugs by trial phase (296 distinct, 379 trials)
Phase 4 (26 own, 0 via acquisition)
Phase 3 (78 own, 0 via acquisition)
Phase 2 (135 own, 0 via acquisition)
Phase 1 (46 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Abruptio Placentae
- Acquired Immunodeficiency Syndrome
- ACTH-Secreting Pituitary Adenoma
- Adenoma
- Adrenoleukodystrophy
- AIDS Dementia Complex
- Alzheimer Disease
- Amyloid Neuropathies
- Amyloid Neuropathies, Familial
- Amyloidosis
- Amyloidosis, Familial
- Amyotrophic Lateral Sclerosis
- Andersen Syndrome
- Anemia
- Anemia, Sickle Cell
- Aneurysm
- Anxiety Disorders
- Aphasia, Primary Progressive
- Arteriovenous Malformations
- Ataxia
- Atherosclerosis
- Atrial Fibrillation
- Atrophy
- Attention Deficit Disorder with Hyperactivity
- Autistic Disorder
- Autonomic Nervous System Diseases
- Back Pain
- Blepharospasm
- Bone Marrow Diseases
- Brain Diseases
- Brain Infarction
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Brain Neoplasms
- Brain Stem Infarctions
- Bronchopulmonary Dysplasia
- Bulbo-Spinal Atrophy, X-Linked
- Cardiovascular Diseases
- Cataplexy
- Causalgia
- Cerebellar Ataxia
- Cerebral Amyloid Angiopathy
- Cerebral Amyloid Angiopathy, Familial
- Cerebral Hemorrhage
- Cerebral Infarction
- Cerebral Palsy
- Chagas Disease
- Chorea
- Chorioamnionitis
- Chronic Pain
- Cognition Disorders
- Cognitive Dysfunction
- Communicable Diseases
- Complex Regional Pain Syndromes
- Congenital Abnormalities
- Constriction, Pathologic
- Conversion Disorder
- Coronary Artery Disease
- Craniocerebral Trauma
- Cysticercosis
- Delirium
- Dementia
- Demyelinating Diseases
- Depression
- Depressive Disorder
- Dermatomyositis
- Disease
- Disorders of Excessive Somnolence
- Dissociative Disorders
- Distal Myopathies
- Drug Resistant Epilepsy
- Dyskinesias
- Dystonia
- Dystonic Disorders
- Encephalomalacia
- Encephalomyelitis
- Endometriosis
- Epilepsies, Partial
- Epilepsy
- Epilepsy, Absence
- Epilepsy, Post-Traumatic
- Epilepsy, Rolandic
- Epilepsy, Temporal Lobe
- Essential Tremor
- Fabry Disease
- Fatigue
- Fatigue Syndrome, Chronic
- Foramen Ovale, Patent
- Fragile X Syndrome
- Friedreich Ataxia
- Frontotemporal Dementia
- Frontotemporal Lobar Degeneration
- Gangliosidoses
- Gangliosidoses, GM2
- Gangliosidosis, GM1
- Gaucher Disease
- Giant Axonal Neuropathy
- Glioblastoma
- Glioma
Recent trials (50)
- NCT06408727CollaboratorN/A—
- NCT06743776CollaboratorN/A—
- NCT05597436CollaboratorN/A—
- NCT06069934CollaboratorN/A—
- NCT07174414CollaboratorPhase 3Aug 31, 2026
- NCT07284290CollaboratorPhase 4Jan 25, 2026
- NCT07204977Lead sponsorPhase 1Dec 2, 2025
- NCT07204977OfficialPhase 1Dec 2, 2025
- NCT06835504CollaboratorPhase 3Sep 1, 2025
- NCT07122453CollaboratorPhase 1Aug 31, 2025
- NCT07227246CollaboratorPhase 3May 6, 2025
- NCT06679374CollaboratorPhase 2Feb 28, 2025
- NCT06629077CollaboratorPhase 2Jan 31, 2025
- NCT06736925CollaboratorPhase 2Jan 31, 2025
- NCT06994949CollaboratorPhase 1Jan 14, 2025
Details
- Founded
- Bethesda, MD, US Jan 1, 1950
- Last known activity
- Aug 31, 2026